Applied Therapeutics, Inc.
Applied Therapeutics, Inc. (APLT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · APLT · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Applied Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
APLT insider buying and selling by quarter
APLT insider selling · APLT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · APLT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
APLT executive sell shares · APLT board member insider trading · APLT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 3, 2026 | Kanter Stacy J. Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | Kanter Stacy J. Director | Other | 42,500 | $4K | Form 4 |
| Dec 19, 2025 | Hooks Corwin Dale Chief Commercial Officer | Award | 312,500 | — | Form 4 |
| Feb 3, 2026 | Hooks Corwin Dale Chief Commercial Officer | Other | 862,500 | $76K | Form 4 |
| Feb 3, 2026 | Hooks Corwin Dale Chief Commercial Officer | Other | 5,753 | — | Form 4 |
| Dec 19, 2025 | Chinoporos Constantine See Remarks | Award | 437,500 | — | Form 4 |
| Feb 3, 2026 | Chinoporos Constantine See Remarks | Other | 1,000,000 | $88K | Form 4 |
| Feb 3, 2026 | Chinoporos Constantine See Remarks | Other | 57,111 | — | Form 4 |
| Feb 3, 2026 | SKYLER JAY S Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | SKYLER JAY S Director | Other | 42,500 | $4K | Form 4 |
| Dec 19, 2025 | Funtleyder Leslie D. CFO · Director | Award | 1,187,500 | — | Form 4 |
| Feb 3, 2026 | Funtleyder Leslie D. CFO · Director | Other | 2,375,000 | $209K | Form 4 |
| Feb 3, 2026 | Funtleyder Leslie D. CFO · Director | Other | 152,959 | — | Form 4 |
| Dec 19, 2025 | Bailey Evan Prescott Chief Medical Officer | Award | 437,500 | — | Form 4 |
| Feb 3, 2026 | Bailey Evan Prescott Chief Medical Officer | Other | 1,235,915 | $109K | Form 4 |
| Feb 3, 2026 | Bailey Evan Prescott Chief Medical Officer | Other | 60,901 | — | Form 4 |
| Feb 3, 2026 | Lerner Teena Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | Lerner Teena Director | Other | 82,922 | $7K | Form 4 |
| Jan 1, 2026 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Dec 16, 2025 | Kanter Stacy J. Director | Sale | 43,000 | $5K | Form 4 |
| Oct 1, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jul 1, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jun 9, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jun 15, 2025 | Bailey Evan Prescott Chief Medical Officer | Award | 300,000 | — | Form 4 |
| Mar 24, 2025 | Hooks Corwin Dale Chief Commercial Officer | Award | 250,000 | — | Form 4 |
Hooks Corwin Dale
Chief Commercial Officer
Date
Dec 19
Shares
312,500
Price
—
Value
—
Hooks Corwin Dale
Chief Commercial Officer
Date
Feb 3
Shares
862,500
Price
$0.09
Value
$76K
Hooks Corwin Dale
Chief Commercial Officer
Date
Feb 3
Shares
5,753
Price
—
Value
—
Chinoporos Constantine
See Remarks
Date
Feb 3
Shares
1,000,000
Price
$0.09
Value
$88K
Funtleyder Leslie D.
CFO · Director
Date
Feb 3
Shares
2,375,000
Price
$0.09
Value
$209K
Bailey Evan Prescott
Chief Medical Officer
Date
Dec 19
Shares
437,500
Price
—
Value
—
Bailey Evan Prescott
Chief Medical Officer
Date
Feb 3
Shares
1,235,915
Price
$0.09
Value
$109K
Bailey Evan Prescott
Chief Medical Officer
Date
Feb 3
Shares
60,901
Price
—
Value
—
Bailey Evan Prescott
Chief Medical Officer
Date
Jun 15
Shares
300,000
Price
—
Value
—
Hooks Corwin Dale
Chief Commercial Officer
Date
Mar 24
Shares
250,000
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About APLT insider trading
APLT insider trades
Applied Therapeutics, Inc. (APLT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Funtleyder Leslie D. (CFO · Director), Bailey Evan Prescott (Chief Medical Officer), Kanter Stacy J. (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. APLT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Applied Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
APLT insider trading · 5 questionsThe insiders of Applied Therapeutics, Inc. (APLT) include executives and directors such as Funtleyder Leslie D. (CFO · Director), Bailey Evan Prescott (Chief Medical Officer), Kanter Stacy J. (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026